Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Elisete Isabel Crocco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rua Barata Ribeiro, São Paulo, Brazil. Hauptthemen laut MEDLINE: Cysteamine, Drug Combinations, Melanosis, Niacinamide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Libbs Farmaceutica LTDA.
Abstract (Originalsprache)
Background
Melasma is a chronic dermatosis that impacts the patient's quality of life and can present considerable challenges in terms of effective treatment.
Objective
To evaluate the effectiveness, tolerability, and safety of 5% cysteamine combined with 4% nicotinamide in female subjects with melasma.
Methods
This single‐center, single‐arm, prospective, open‐label study evaluated patients with melasma using a combination cream of 5% cysteamine and 4% nicotinamide in a progressive regimen (60 min in the first month, 120 min in the second month, and 180 min in the third month).
Results
Overall, 35 treated subjects exhibited reduced modified Melasma Area and Severity Index (mMASI) ( p < 0.001) and decreased MelasQoL scores ( p < 0.001), accompanied by improved brightness, luminosity, homogeneity, and spot intensity ( p < 0.001). Photographic and colorimetric analysis revealed smaller spots and improved homogeneity.
Limitations
Adherence to progressive daily treatment could not be evaluated long‐term.
Conclusion
A combination cream comprising 5% cysteamine and 4% nicotinamide was effective, tolerable, and safe for treating melasma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rua Barata Ribeiro, São Paulo, Brazil.
ORCID-Profile: Elisete Isabel Crocco
Förderung
- Libbs Farmaceutica LTDA
Zitieren
APA
Crocco, E. I., Torloni, L., Fernandes, P. B., de Campos, M. E. B. B., Gonzaga, M., Silva, F. C., Nasario, J. P. S., Guerra, L. O., Csipak, A. R., & Castilho, V. C. (2024). Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16183
Vancouver
Crocco EI, Torloni L, Fernandes PB, de Campos MEBB, Gonzaga M, Silva FC, et al. Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16183
BibTeX
@article{Crocco2024,
author = {Crocco, Elisete Isabel and Torloni, Liliana and Fernandes, Paula Bonilha and de Campos, Maria Elisa Barbosa Bueno and Gonzaga, Maura and Silva, Fernanda Cristina and Nasario, João Paulo Sardin and Guerra, Lucas Offenbecker and Csipak, Angélica Richart and Castilho, Vivienne Carduz},
title = {Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16183}
}
EUVIMED